HOPMAN MARK (Chief Commercial Officer) sold 0.9% of their position (775.00 shares) of BETA BIONICS, INC. on the open market
Open‑market sale worth $12.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/15/2026ACC: 0002048497-26-000014
Officer· Chief Commercial Officer
Since Mar 2026
-775.00
Net shares
Net seller
$12.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
775.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−775.00
Price / share
$15.52
Trade value
$12.03K
% of position
0.9%
9/14/2026
87.16K→86.38K
Total
Net shares
−775.00
Net value
-$12.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/14/2026 | S · Sale | −775.00 | $15.52 | $12.03K | 0.9% | 87.16K | 86.38K |
| Total | −775.00 | -$12.03K | ||||||
Derivative Transactions0
No derivative transactions reported